Advisory bodies and committees
Information on the statutory advisory committees, working groups and industry consultation groups that support the work of the TGA.
Latest articles
-
Access Generic Medicines work-sharing initiative operational procedures update
We are advising sponsors of updates to the Generic Medicines Work-Sharing Initiative (GMWSI) operational procedures. -
Vacancies on advisory committees
We are seeking applications from professionals with expertise in medicine and science, and from consumers with expertise in consumer perspectives and issues. -
TGA supports MHRA’s new international recognition framework for medicines
These international recognition routes, which have been facilitated by existing international partnerships such as those developed through the Access Consortium and Project Orbis, are part of a new international recognition framework for medicines that is specific to the UK following their exit from the European Union.
Latest publications
-
Read the meeting statement from 12 December 2024 meeting of the Advisory Committee on Medical Devices
-
Communique from the 1st meeting of the Human Research Ethics Committee and TGA Clinical Trials Discussion Forum, 27 November 2024
-
Advisory Committee on Complementary Medicines meeting statement for 14 March 2024
Open consultations
-
Consultation: Proposed amendments to the Poisons Standard – ACCS and Joint ACMS-ACCS meetings – March 2025
Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Chemicals Scheduling (ACCS) and joint meeting of the Advisory Committee on Medicines Scheduling (ACMS) and ACCS.